Skip to main content

Down-regulation of miR-29c in human bladder cancer and the inhibition of proliferation in T24 cell via PI3K-AKT pathway

Medical Oncology volume 31, Article number: 65 (2014) Cite this article

Abstract

The purpose of this study was to explore new tumor suppressor microRNA in bladder cancer and to conduct functional analysis of its suppressive role. To investigate the expression of miR-29c, qRT-PCR was used in 30 pairs of bladder cancer tissues and normal tissues (adjacent bladder tissue samples). The expression of miR-29c was down regulated in bladder cancer tissues compared with normal tissues. Also, the low-level expression of miR-29c was associated with tumor stage (P = 0.002), and ectopic over-expression of miR-29c in T24 cells can significantly inhibit cell proliferation, decrease motility, suppress the G1/S cell cycle transition and induce apoptosis. Furthermore, it could cause a decrease in AKT and GSK-3β phosphorylation. While LY294002 reduced the protein level of pAKT, the over-expression of miR-29c can further decrease its level in T24 cells pretreated with LY294002. Our study also indicated that the proliferation inhibition of T24 may take place via AKT-GSK3β pathway. Thus, miR-29c could be an active player in disease state of bladder cancer and it may be a promising tumor suppressor in bladder cancer.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

References

  1. Ying SY, Chang DC, et al. The microRNA (miRNA): overview of the RNA genes that modulate gene function. Mol Biotechnol. 2008;38:257–68.

    CAS  PubMed  Article  Google Scholar 

  2. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136:215–33.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  3. Khan S, Brougham CL, Ryan J, et al. miR-379 regulates cyclin B1 expression and is decreased in breast cancer. PLoS ONE. 2013;8:e68753.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  4. Liu R, Li J, Teng Z, et al. Overexpressed microRNA-182 promotes proliferation and invasion in prostate cancer PC-3 cells by down-regulating N-myc downstream regulated gene 1 (NDRG1). PLoS ONE. 2013;8:e68982.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  5. Van Kouwenhove M, Kedde M, Agami R. MicroRNA regulation by RNA-binding proteins and its implications for cancer. Nat Rev Cancer. 2011;11:644–56.

    PubMed  Article  Google Scholar 

  6. Jemal A, Siegel R, Ward E, et al. Cancer statistics. CA Cancer J Clin. 2009;59:225–49.

    PubMed  Article  Google Scholar 

  7. Ismaili N, Amzerin M, Flechon A. Chemotherapy in advanced bladder cancer: current status and future. J Hematol Oncol. 2011;4:35.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  8. Wallerand H, Reiter RR, Ravaud A. Molecular targeting in the treatment of either advanced or metastatic bladder cancer or both according to the signalling pathways. Curr Opin Urol. 2008;18:524–32.

    PubMed  Article  Google Scholar 

  9. Netto GJ, Epstein JI. Theranostic and prognostic biomarkers: genomic applications in urological malignancies. Pathology. 2010;42:384–94.

    PubMed  Article  Google Scholar 

  10. Gottardo F, Liu CG, Ferracin M, et al. Micro-RNA profiling in kidney and bladder cancers. Urol Oncol. 2007;25:387–92.

    CAS  PubMed  Article  Google Scholar 

  11. Dyrskjøt L, Ostenfeld MS, Bramsen JB, et al. Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro. Cancer Res. 2009;69:4851–60.

    PubMed  Article  Google Scholar 

  12. Wang S, Xue S, Dai Y, et al. Reduced expression of microRNA-100 confers unfavorable prognosis in patients with bladder cancer. Diagn Pathol. 2012;7:159.

    PubMed Central  PubMed  Article  Google Scholar 

  13. Nguyen T, Kuo C, Nicholl MB, et al. Downregulation of microRNA-29c is associated with hypermethylation of tumor-related genes and disease outcome in cutaneous melanoma. Epigenetics. 2011;6:388–94.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  14. Castilla MÁ, Moreno-Bueno G, Romero-Pérez L, et al. Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma. J Pathol. 2011;223:72–80.

    CAS  PubMed  Article  Google Scholar 

  15. Li Y, Wang F, Xu J, et al. Progressive miRNA expression profiles in cervical carcinogenesis and identification of HPV-related target genes for miR-29. J Pathol. 2011;224:484–95.

    CAS  PubMed  Article  Google Scholar 

  16. Morita S, Horii T, Kimura M, et al. miR-29 represses the activities of DNA methyltransferases and DNA demethylases. Int J Mol Sci. 2013;14:14647–58.

    PubMed Central  PubMed  Article  Google Scholar 

  17. Park SY, Lee JH, Ha M, et al. miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42. Nat Struct Mol Biol. 2009;16:23–9.

    CAS  PubMed  Article  Google Scholar 

  18. Li L, Sarver AL, Alamgir S, et al. Downregulation of microRNAs miR-1, -206 and -29 stabilizes PAX3 and CCND2 expression in rhabdomyosarcoma. Lab Invest. 2012;92:571–83.

    CAS  PubMed  Article  Google Scholar 

  19. Heinzelmann J, Henning B, Sanjmyatav J, et al. Specific miRNA signatures are associated with metastasis and poor prognosis in clear cell renal cell carcinoma. World J Urol. 2011;29:367–73.

    CAS  PubMed  Article  Google Scholar 

  20. Schaefer A, Jung M, Mollenkopf HJ, et al. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma. Int J Cancer. 2010;126:1166–76.

    CAS  PubMed  Google Scholar 

  21. Zhao JJ, Lin J, Lwin T, et al. microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma. Blood. 2010;115:2630–9.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  22. Mott JL, Kobayashi S, Bronk SF, et al. Mir-29 regulates Mcl-1 protein expression and apoptosis. Oncogene. 2007;26:6133–40.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  23. Garzon R, Heaphy CE, Havelange V, et al. MicroRNA 29b functions in acute myeloid leukemia. Blood. 2009;114:5331–41.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  24. Wang Y, Zhou BP. Epithelial-mesenchymal transition in breast cancer progression and metastasis. Chin J Cancer. 2011;30:603–11.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  25. Yang Tao, Liang Ying, Lin Qinlu, et al. MiR-29 mediates TGFβ1 -induced extracellular matrix synthesis through activation of PI3 K-AKT pathway in human lung fibroblasts. J Cell Biochem. 2013;114:1336–42.

    CAS  PubMed  Article  Google Scholar 

  26. Vivanco I, Sawyers CL. The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev Cancer. 2002;2:489–501.

    CAS  PubMed  Article  Google Scholar 

  27. Paez J, Sellers WR. PI3 K/PTEN/AKT pathway. A critical mediator of oncogenic signaling. Cancer Treat Res. 2003;115:145–67.

    CAS  PubMed  Article  Google Scholar 

  28. Knowles MA, Platt FM, Ross RL, et al. Phosphatidylinositol 3-kinase (PI3K) pathway activation in bladder cancer. Cancer Metastasis Rev. 2009;28:305–16.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  29. Manning BD, Cantley LC. AKT/PKB signaling: navigating down- stream. Cell. 2007;129:1261–74.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  30. Noguchi S, Yasui Y, Iwasaki J, et al. Replacement treatment with microRNA-143 and -145 induces synergistic inhibition of the growth of human bladder cancer cells by regulating PI3K/Akt and MAPK signaling pathways. Cancer Lett. 2013;328:353–61.

    CAS  PubMed  Article  Google Scholar 

  31. Wei W, He HB, Zhang WY, et al. miR-29 targets Akt3 to reduce proliferation and facilitate differentiation of myoblasts in skeletal muscle development. Cell Death Dis. 2013;4:e668.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  32. Yang T, Liang Y, Lin Q, et al. miR-29 mediates TGFbeta1-induced extracellular matrix synthesis through activation of PI3K-AKT pathway in human lung fibroblasts. J Cell Biochem. 2013;114:1336–42.

    CAS  PubMed  Article  Google Scholar 

Download references

Conflict of interest

None.

Author information

Affiliations

  1. The Key Laboratory of Diagnostics Medicine Designated by the Ministry of Education, Chongqing Medical University, Chongqing, People’s Republic of China

    Yanru Fan, Xuedong Song, Hongfei Du, Chunli Luo, Xiaorong Wang, Xue Yang & Yin Wang

  2. Department of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People’s Republic of China

    Xiaohou Wu

Authors
  1. Yanru Fan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xuedong Song
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hongfei Du
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Chunli Luo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xiaorong Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Xue Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yin Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Xiaohou Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chunli Luo.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Fan, Y., Song, X., Du, H. et al. Down-regulation of miR-29c in human bladder cancer and the inhibition of proliferation in T24 cell via PI3K-AKT pathway. Med Oncol 31, 65 (2014). https://doi.org/10.1007/s12032-014-0065-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12032-014-0065-x

Keywords

  • miR-29c
  • Bladder cancer
  • Proliferation
  • Apoptosis
  • Migration
  • AKT